Jpmorgan Chase & Co »

Aktis Oncology shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Aktis Oncology (AKTS) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $266k 8.8k 30.11
2026-03-31 $138k 8.4k 16.54